价格

IDO T

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Regulation of T cell-mediated immunity by tryptophan
US 7160539 B2申请人: MEDICAL COLLEGE OF GEORGIA优先权: 2000
US
9 件公开
INDOLEAMINE 2, 3-DIOXYGENASE BASED IMMUNOTHERAPY
EP 3915570 A1申请人: IO BIOTECH APS优先权: 2008
CN
EP
US
8 件公开
Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
- US 2006292618 A1
  申请人: MELLOR ANDREW L优先权: 2006
  US
  6 件公开
- EP 2177601 A1
  申请人: MED COLLEGE GEORGIA RES INST优先权: 2002
  EP
  US
  2 件公开
Synergistic combination of immunologic inhibitors for the treatment of cancer
US 10034939 B2申请人: UNIV CHICAGO优先权: 2012
US
WO
5 件公开
Annulins A, B, C or analogs as indoleamine 2,3-dioxygenase (IDO) inhibitors for treatment of cancer
EP 2130826 A1申请人: UNIV BRITISH COLUMBIA优先权: 2004
CN
EP
US
4 件公开
REDUCING SYSTEMIC REGULATORY T CELL LEVELS OR ACTIVITY FOR TREATMENT OF DISEASE AND INJURY OF THE CNS
EP 4591880 A3申请人: YEDA RES & DEV优先权: 2015
EP
WO
2 件公开
L-TRYPTOPHAN-PRODUCING ENGINEERED STRAIN OF CLOSTRIDIUM BUTYRICUM AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING TUMORS
WO 2026000538 A1申请人: UNIV SOOCHOW优先权: 2024
CN
WO
2 件公开
Tranilast as modulator of T cell functioning for use in the treatment of autoimmune diseases
EP 2253313 A1申请人: UNIV LELAND STANFORD JUNIOR优先权: 2006
EP
METHOD OF MODULATING T CELL FUNCTIONING
US 2008009519 A1申请人: STEINMAN LAWRENCE优先权: 2007
US
METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS
US 2011305713 A1申请人: MUNN DAVID H优先权: 2011
US

药物

IDO T

专利

Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance